The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
There is ample evidence to support the use of spinal cord stimulation in the treatment of refractory painful diabetic neuropathy.[1, 2] Adverse effects of spinal cord stimulator implant have been well documented and include the risks of lead migration, infection, spinal cord injury, intolerance, and others.[3] However, there have been few reports of diabetic ketoacidosis following this intervention.
Disclosures
Nothing to Disclose by any Author
Speaker(s):
Daniel
Adams,
PA-C, MSHS,
Associate Research Coordinator, Physician Assistant,
Western Reserve Hospital
Morgan
Mingo,
NP,
Nurse Practitioner,
Western Reserve Hospital - Center for Pain Medicine
Bethany
Pontius,
NP,
Nurse Practitioner,
Western Reserve Hospital
Nicole
Souza,
Research Intern,
Western Reserve Hospital
Claire
Hubert,
MS-3,
Medical Student,
AT Still University
Kanchen
Loganathan,
DO,
Resident, Internal Medicine,
Western Reserve Hospital
Dr. Dmitri
Souza,
MD, PhD,
Clinical Professor of Anesthesiology,
Ohio University College of Medicine (OUCOM)
You must be logged in and own this session in order to
post comments.